The goal of the proposed research is to understand how adhesion regulates cell proliferation. The focus will be on the Abl tyrosine kinase as a transducer of the growth regulatory signal. The ubiquitous c-Abl is localized in the cytoplasm and the nucleus. The nuclear c-abl binds DNA and regulates transcription. The cytoplasmic c-abl interacts with both G and F-actin. Recently, a collaboration between two units of this program has demonstrated that the kinase activity and the subcellular localization of c-Abl is regulated by the adherent status of a cell. In addition, overexpression of a kinase-defective c-Abl can interfere with adhesion-mediated activation of MAP kinase. The c-Abl kinase is constitutively activated by fusion with Bcr sequences in the Bcr-Abl protein produced from the Philadelphia chromosome in chronic myelogenous leukemia (CML). The targets of transformation in CML are the pluripotent stem cells which are adherent to the bone marrow stroma. The CML stem cells show reduced adhesion and this defect is correlated with the diseased state. In a fibroblast model we have developed, Bcr-Abl is also found to affect the adhesive function. Moreover, Bcr-Abl can abrogate the adhesion requirement to promote anchorage-independent growth, but does not function as a mitogen. Taken together, these observations suggest a model in which regulated activation of c-Abl tyrosine kinase transduces adhesion signal to promote normal growth, and a deregulated Bcr-Abl signals independently of adhesion to cause transformation. To test this hypothesis, we propose to pursue four specific aims.
In Aim 1, the functional domains required for c-Abl to respond to adhesion will be identified and the abl+/+ and abl-/- cells will be compared for their response to adhesion.
In Aim 2, the mechanism by which Bcr-Abl affects adhesion will be investigated.
In Aim 3, downstream targets of c-Abl and Bcr-Abl in the adhesion-regulated pathways will be identified, in particular the pathways regulated by Rho and the activation of MAP kinase. We have shown p130cas to be a potential substrate of Bcr-Abl, and will identify others. We will also isolate genes that are commonly regulated by adhesion and by Bcr-Abl. The goal is to obtain nuclear targets with which to better understand the adhesion-regulated pathways.
In Aim 4, we will examine the function of Abl targets in the regulation of cell proliferation. Results and reagents obtained from the experiments conducted with the fibroblast model will be extended to hematopoietic cells and utimately in long- term bone marrow culture to study the Abl tryosine kinase in the control of stem cell proliferation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL057900-02
Application #
6273266
Study Section
Project Start
1998-04-01
Project End
1999-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Wilson, RaeAnna; Espinosa-Diez, Cristina; Kanner, Nathan et al. (2016) MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment. Nat Commun 7:13597
Liao, Zhongji; Kato, Hisashi; Pandey, Manjula et al. (2015) Interaction of kindlin-2 with integrin ?3 promotes outside-in signaling responses by the ?V?3 vitronectin receptor. Blood 125:1995-2004
Desgrosellier, Jay S; Lesperance, Jacqueline; Seguin, Laetitia et al. (2014) Integrin ?v?3 drives slug activation and stemness in the pregnant and neoplastic mammary gland. Dev Cell 30:295-308
Fitzpatrick, Paul; Shattil, Sanford J; Ablooglu, Ararat J (2014) C-terminal COOH of integrin ?1 is necessary for ?1 association with the kindlin-2 adapter protein. J Biol Chem 289:11183-93
Seguin, Laetitia; Kato, Shumei; Franovic, Aleksandra et al. (2014) An integrin ??-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nat Cell Biol 16:457-68
Casar, B; Rimann, I; Kato, H et al. (2014) In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated ?1 integrin and induction of FAK/PI3K/Akt motility signaling. Oncogene 33:255-68
Ye, Feng; Petrich, Brian G; Anekal, Praju et al. (2013) The mechanism of kindlin-mediated activation of integrin ?IIb?3. Curr Biol 23:2288-2295
Scheppke, Lea; Murphy, Eric A; Zarpellon, Alessandro et al. (2012) Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane. Blood 119:2149-58
Cantor, Joseph M; Ginsberg, Mark H (2012) CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci 125:1373-82
Banno, Asoka; Goult, Benjamin T; Lee, HoSup et al. (2012) Subcellular localization of talin is regulated by inter-domain interactions. J Biol Chem 287:13799-812

Showing the most recent 10 out of 79 publications